Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy

Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy

Abstract The reported frequency and types of adverse events following initial vaccination and revaccination with Bacille Calmette-Guérin (BCG) varies worldwide. Using active surveillance in a randomised controlled trial of BCG vaccination (the BRACE trial), we determined the incidence and risk facto...

Full description

Bibliographic Details
Main Authors: Paola Villanueva, Ushma Wadia, Nigel Crawford, Nicole L. Messina, Tobias R. Kollmann, Michaela Lucas, Laurens Manning, Peter Richmond, Laure F. Pittet, Nigel Curtis
Format: Article
Language:English
Published: Nature Portfolio 2022-01-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-021-00421-5

Internet

https://doi.org/10.1038/s41541-021-00421-5

Similar Items